UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043530
Receipt number R000049709
Scientific Title The analysis of clinical data of infections due to COVID-19
Date of disclosure of the study information 2021/03/05
Last modified on 2021/03/05 15:55:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The research on infections due to COVID-19

Acronym

The research on COVID-19

Scientific Title

The analysis of clinical data of infections due to COVID-19

Scientific Title:Acronym

The analysis of COVID-19

Region

Japan


Condition

Condition

COVID-19 infection

Classification by specialty

Infectious disease

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We analyze the clinical data from the patients with COVID-19 to contribute for the progress in medical care for OVID-19.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We analyze the data which are possible to the clinical course and the prognosis for patients with COVID-19.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The inpatients with COVID-19 in Kawasaki Medical School from 1st January 2020 to 31th December 2024

Key exclusion criteria

Of all objective patients, the people who reject to enroll this research.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Tomohiro
Middle name
Last name Oishi

Organization

Kawasaki Medical School

Division name

Pediatrics

Zip code

7010192

Address

577 Matsushima Kurashik-shi Okayama

TEL

086-462-1111

Email

oo0612@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name Tomohiro
Middle name
Last name Oishi

Organization

Kawasaki Medical School

Division name

Pediatrics

Zip code

7010192

Address

577 Matsushima Kurashik-shi Okayama

TEL

086-462-1111

Homepage URL


Email

oo0612@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Kawasaki Medical School

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kawasaki Medical School

Address

577 Matsushima Kurashik-shi Okayama

Tel

086-462-1111

Email

oo0612@med.kawasaki-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 03 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 03 Month 05 Day

Date of IRB


Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

No particular


Management information

Registered date

2021 Year 03 Month 05 Day

Last modified on

2021 Year 03 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049709


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name